Mircea Dediu

Researcher Next ID · RN-014205

Researcher · Medicine

, Romania

Not currently recruitingFunding unknown

Research interests

Medicine

Lung Cancer Treatments and Mutations

Lung Cancer Diagnosis and Treatment

Lung Cancer Research Studies

HER2/EGFR in Cancer Research

Colorectal Cancer Treatments and Studies

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
The Lancet · 2019 · 10.1016/s0140-6736(18)32409-7
Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial
The Lancet Oncology · 2015 · 10.1016/s1470-2045(15)00021-2
PARAMOUNT: Final Overall Survival Results of the Phase III Study of Maintenance Pemetrexed Versus Placebo Immediately After Induction Treatment With Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non–Small-Cell Lung Cancer
Journal of Clinical Oncology · 2013 · 10.1200/jco.2012.47.1102
Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial
The Lancet Oncology · 2012 · 10.1016/s1470-2045(12)70063-3
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
New England Journal of Medicine · 2005 · 10.1056/nejmoa050753

No projects listed.